| Literature DB >> 26805803 |
Na Yang1, Aizhen Xiong2,3, Rui Wang4,5, Li Yang6,7, Zhengtao Wang8,9.
Abstract
XiaoyanLidan tablets (XYLDTs) are traditional Chinese medicines frequently used for syndromes of the liver and gallbladder, cholecystitis and cholangitis. To evaluate the consistency of the quality of commercial XYLDT preparations, we established a simple and reliable ultra-performance liquid chromatography (UPLC) method with a photodiode array (PDA) detector and mass spectrometry (MS), including a fingerprint analysis and quantification of the main pharmacologically-active markers. In the UPLC-PDA detection-based fingerprint analysis of XYLDTs, approximately 39 peaks were found in the XYLDT chromatogram, 26 of which were attributed to Picrasmaquassioides, nine to Andrographis and four to Isodonserra. Subsequently, the structures of these bioactive markers were identified through ESI-MS analyses. Using the chemometricmethods of similarity analysis and principal component analysis, the five significant herbal componentswere determined as 4-methoxy-5-hydroxycanthin-6-one, andrographolide, dehydroandrographolide, neoandrographolide and rosmarinic acid, and these components were qualitatively assessed. Our experimental results demonstrated that combining the fingerprint analysis with UPLC-MS and multi-ingredient determination is useful for rapid pharmaceutical quality evaluation. Moreover, the combined approach can potentially differentiate the origin, determine the authenticity and assess the overall quality of the formulae.Entities:
Keywords: UPLC-MS; XiaoyanLidan tablets; chromatographic fingerprint; formulae; traditional Chinese medicine
Mesh:
Substances:
Year: 2016 PMID: 26805803 PMCID: PMC6273587 DOI: 10.3390/molecules21020083
Source DB: PubMed Journal: Molecules ISSN: 1420-3049 Impact factor: 4.411
Figure 1Chemical structures of the five bioactive components of XYLDTs.
Figure 2UPLC-UV fingerprint chromatograms of XYLDTs (S1) and three crude herbs, Isodon serra (S2), Andrographis (S3), and Picrasma quassioides (S4).
Characterization of 15 compounds identified from XYLDT.
| Peak Number | RT | MS ( | MS2 ( | Compounds |
|---|---|---|---|---|
| 2 | 5.43 | 251 | 168 | 3-Methylcanthin-5,6-dione |
| 5 | 6.45 | 243 | 213 | 1-ethyl-4-Methoxy-8-hydroxycanthin-β-carboline |
| 9 | 8.66 | 257 | 197 | 4,8-Dimethoxyl-1-ethyl-carboline |
| 14 | 9.67 | 267 | 168 | 4-Methoxy-5-hydroxycanthin-6-one |
| 23 | 16.89 | 281 | 237 | 4,5-Dimethoxycanthin-6-one |
| 27 | 21.74 | 241 | 213 | 1-Ethenyl-4-methoxy-8-hydroxycanthin-β-carboline |
| 29 | 22.51 | 481 | 253 | Picradidine H |
| 30 | 24.04 | 495 | 253 | Picradidine C |
| 31 | 24.85 | 225 | 197 | 1-Ethenyl-4-methoxy-β-carboline |
| 33 | 25.81 | 479 | 267 | Picradidine F |
| 37 | 26.86 | 255 | 197 | 1-Ethenyl-4,8-dimethoxyl-β-carboline |
| 15 | 10.16 | 351 | 211 | Andrographolide |
| 22 | 17.55 | 481 | 237 | Neoandrographolide |
| 28 | 22.13 | 333 | 297 | Dehydroandrographolide |
| 24 | 17.57 | 361 | 139 | Rosmarinic acid |
| others | - | - | - | Unknown |
Figure 3The scores plot obtained by PCA of the 113 samples, LFS (1), BYS (2), WNQ (3), JY (4), XF (5), JK (6), BH (7), GF (8), JM (9), YH (10), QZ (11), LS (12) and QT (13).
Figure 4The loading plot for the common peaks, 4-methoxy-5-hydroxycanthin-6-one (14), andrographolide (15), neoandrographolide (22), rosmarinic acid (24) and dehydroandrographolide (28).
Precision, reproducibility and stability for the analysis of the five bioactive compounds.
| Compound | Precision ( | Reproducibility ( | Stability ( | |||
|---|---|---|---|---|---|---|
| Content (mg·Tab−1) | RSD (%) | Content (mg·Tab−1) | RSD (%) | Content (mg·Tab−1) | RSD (%) | |
| 4-Methoxy-5-hydroxycanthin-6-one | 0.5273 | 2.94 | 0.5394 | 2.78 | 0.5414 | 2.61 |
| Andrographolide | 8.4279 | 0.11 | 8.3933 | 0.54 | 8.4387 | 0.18 |
| Dehydroandrographolide | 4.4402 | 0.20 | 4.5892 | 1.55 | 4.5711 | 0.80 |
| Neoandrographolide | 2.5032 | 2.14 | 2.5326 | 1.68 | 2.4955 | 1.70 |
| Rosmarinic acid | 2.2165 | 0.30 | 2.2200 | 0.66 | 2.2264 | 0.62 |
Recovery for the analysis of the five bioactive compounds.
| Compound | Original (mg) | Spiked (mg) | Found (mg) | Recovery (%) | Average Recovery (%) | RSD (%) ( |
|---|---|---|---|---|---|---|
| 4-Methoxy-5-hydroxycanthin-6-one | 0.3236 | 0.1511 | 0.4827 | 103.7 | 102.4 | 2.54 |
| 0.3022 | 0.6304 | 100.0 | ||||
| 0.4533 | 0.7966 | 103.4 | ||||
| Andrographolide | 5.0360 | 2.5444 | 7.6376 | 100.8 | 100.1 | 1.32 |
| 5.0888 | 10.2118 | 100.3 | ||||
| 7.6332 | 12.6637 | 99.1 | ||||
| Dehydroandrographolide | 2.7535 | 1.3812 | 4.1851 | 102.2 | 103.3 | 1.53 |
| 2.7624 | 5.6323 | 102.8 | ||||
| 4.1436 | 7.1293 | 104.8 | ||||
| Neoandrographolide | 1.5196 | 0.7509 | 2.2602 | 97.2 | 97.2 | 1.02 |
| 1.5018 | 3.0400 | 99.8 | ||||
| 2.2527 | 3.8956 | 104.6 | ||||
| Rosmarinic acid | 1.3320 | 0.6505 | 1.9989 | 101.0 | 100.9 | 2.44 |
| 1.3010 | 2.6874 | 98.0 | ||||
| 1.9515 | 3.2809 | 102.1 |
Calibration curves for the analysis of the five bioactive compounds.
| Compound | Regression Equation ( | Linear Range (μg·mL−1) | |
|---|---|---|---|
| 4-Methoxy-5-hydroxycanthin-6-one | 0.9999 | 0.50–32.16 | |
| Andrographolide | 0.9999 | 10.00–160.02 | |
| Dehydroandrographolide | 1.0000 | 40.13–200.65 | |
| Neoandrographolide | 1.0000 | 17.03–122.64 | |
| Rosmarinic acid | 0.9999 | 1.91–61.25 |
Figure 5The bar graph of the average concentrations of five components in samples from 18 manufactures.